Drug details
Uplizna (inebilizumab-cdon injection)
type of Monoclonal Antibodies
Uplizna (inebilizumab-cdon) is a CD19-directed cytolytic antibody used to treat neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
This drug may have the following side effects:
- joint pain,
- headache, and
- urinary tract infection (UTI),
- back pain
The following drugs are related to Uplizna, either as a replacement or used together:
- Soliris (eculizumab)
- Enspryng (satralizumab-mwge injection for subcutaneous administratio)
- Rituxan (rituximab)
- Rituxan Hycela (rituximab and hyaluronidase human injection)